Experimental MG treatment trial stopped early after testing in 9 patients
NCT ID NCT06965309
First seen Feb 16, 2026 · Last updated May 03, 2026 · Updated 10 times
Summary
This early study tested a new treatment called HN2301 in 9 adults with refractory myasthenia gravis, a severe muscle weakness condition. The main goal was to check safety and side effects. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai General Hospital (Songjiang Branch) of Shanghai Jiao Tong University School of Medicine
Shanghai, 201600, China
Conditions
Explore the condition pages connected to this study.